Product Description: ADH-1, an N-cadherin antagonist, inhibits N-cadherin mediated cell adhesion.
Applications: Cancer-Kinase/protease
Formula: C22H34N8O6S2
References: [1]Shintani Y, et al. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer. 2008 Jan 1;122(1):71-7./[2]Li H, et al. ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer. Anticancer Drugs. 2007 Jun;18(5):563-8./[3]Turley RS, et al. Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma. Ann Surg. 2015 Feb;261(2):368-77
CAS Number: 229971-81-7
Molecular Weight: 570.69
Compound Purity: 99.93
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Cadherin